How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
- PMID: 34604808
- PMCID: PMC8463729
- DOI: 10.1016/j.jaccao.2021.05.005
How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
Keywords: CT, computed tomography; TEG, thromboelastography; bleeding; echocardiography; imaging; outcomes; pericardial disease; pericardiocentesis; provider education; thrombocytopenia; treatment.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures



Similar articles
-
Overview of Optimal Techniques for Pericardiocentesis in Contemporary Practice.Curr Cardiol Rep. 2020 Jun 19;22(8):60. doi: 10.1007/s11886-020-01324-y. Curr Cardiol Rep. 2020. PMID: 32562136 Review.
-
Computed tomography-guided pericardiocentesis - A single-center experience.Rev Port Cardiol. 2016 May;35(5):285-90. doi: 10.1016/j.repc.2015.11.015. Epub 2016 Apr 24. Rev Port Cardiol. 2016. PMID: 27118093 English, Portuguese.
-
Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia.Front Cardiovasc Med. 2021 Apr 21;8:638943. doi: 10.3389/fcvm.2021.638943. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33969007 Free PMC article.
-
Quantification of pericardial effusions by echocardiography and computed tomography.Am J Cardiol. 2011 Jan 15;107(2):331-5. doi: 10.1016/j.amjcard.2010.08.072. Am J Cardiol. 2011. PMID: 21211612
-
Pericardial effusions: do they all require pericardiocentesis?Can J Cardiol. 2015 Jun;31(6):812-5. doi: 10.1016/j.cjca.2015.01.006. Epub 2015 Jan 21. Can J Cardiol. 2015. PMID: 26022991 Review.
Cited by
-
Prevalence, characteristics and mortality of cancer patients undergoing pericardiocentesis in the United States between 2004 and 2017.Cancer Med. 2023 Mar;12(5):5471-5484. doi: 10.1002/cam4.5373. Epub 2022 Oct 20. Cancer Med. 2023. PMID: 36266946 Free PMC article.
-
The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience.Front Cardiovasc Med. 2022 Sep 21;9:1013979. doi: 10.3389/fcvm.2022.1013979. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211575 Free PMC article.
-
Case report: CAR-T cell therapy-induced cardiac tamponade.Front Cardiovasc Med. 2023 Mar 20;10:1132503. doi: 10.3389/fcvm.2023.1132503. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37020516 Free PMC article.
-
Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis.Front Cardiovasc Med. 2022 May 31;9:916325. doi: 10.3389/fcvm.2022.916325. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35711368 Free PMC article.
-
Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: JACC: CardioOncology State-of-the-Art Review.JACC CardioOncol. 2024 Aug 20;6(4):475-495. doi: 10.1016/j.jaccao.2024.06.004. eCollection 2024 Aug. JACC CardioOncol. 2024. PMID: 39239331 Free PMC article. Review.
References
-
- Jama G.M., Scarci M., Bowden J. Palliative treatment for symptomatic malignant pericardial effusion. Interact Cardiovasc Thorac Surg. 2014;19:1019–1026. - PubMed
-
- Vaitkus P., Hermann H., LeWinter M. Treatment of malignant pericardial effusion. JAMA. 1994;272:59–64. - PubMed
-
- Apodaca-Cruz A., Villarreal-Garza C., Torres-Avila B. Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion. Interact Cardiovasc Thorac Surg. 2010;11:154–161. - PubMed
Publication types
LinkOut - more resources
Full Text Sources